tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yatin Suneja, 350 are a BUY (89.06%), 42 are a HOLD (10.69%), 1 are a SELL (0.25%).
Analyst Yatin Suneja, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 42.74% that have a potential upside of 60.5% achieved within 306 days.
Yatin Suneja’s has documented 731 price targets and ratings displayed on 61 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABVX, Abivax SA.
Analyst best performing recommendations are on PRNB (PRINCIPIA BIOPHARMA).
The best stock recommendation documented was for IMVT (IMMUNOVANT) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2024
$35
$15.2 (76.77%)
$35
Buy Since 22-Jun-2025
$36
$16.2 (81.82%)
$37
13 days ago
(07-Oct-2026)
1/10 (10%)
$16.42 (83.86%)
173
Buy Since 14-Dec-2025
$33
$13.2 (66.67%)
$37
26 days ago
(24-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 16-Apr-2025
$34
$14.2 (71.72%)
$36
26 days ago
(24-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 24-Sep-2025
$31
$11.2 (56.57%)
$38
26 days ago
(24-Sep-2026)
1/4 (25%)
$10.32 (49.90%)
831
Which stock is Yatin Suneja most bullish on?
Which stock is Yatin Suneja most reserved on?
What Year was the first public recommendation made by Yatin Suneja?
